Alan J Kivitz Selected Research

fasinumab

1/2021	Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial.
11/2019	The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
7/2014	Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan J Kivitz Research Topics

Disease

33	Rheumatoid Arthritis 02/2022 - 03/2005
14	Pain (Aches) 01/2021 - 11/2004
12	Psoriatic Arthritis 02/2022 - 07/2004
8	Infections 02/2022 - 05/2007
8	Osteoarthritis 01/2022 - 05/2004
7	Knee Osteoarthritis 01/2022 - 05/2004
6	Ankylosing Spondylitis 07/2022 - 01/2018
6	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 07/2004
5	Inflammation (Inflammations) 12/2018 - 11/2009
4	Headache (Headaches) 02/2022 - 01/2013
4	Low Back Pain (Lumbago) 01/2021 - 01/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 08/2008
3	Arthritis (Polyarthritis) 01/2017 - 12/2007
3	Osteoporosis 01/2017 - 10/2003
2	Herpes Zoster 01/2022 - 01/2017
2	Paresthesia (Dysesthesia) 01/2022 - 01/2013
2	Axial Spondyloarthritis 01/2021 - 01/2017
2	Bone Resorption 03/2020 - 02/2006
2	Hypersensitivity (Allergy) 01/2019 - 12/2017
2	Human Influenza (Influenza) 04/2014 - 02/2007
2	Disease Progression 04/2006 - 07/2004
1	Opportunistic Infections (Opportunistic Infection) 01/2022
1	Hypesthesia (Numbness) 01/2022
1	Orthostatic Hypotension (Postural Hypotension) 01/2022
1	Nasopharyngitis 01/2022
1	Bradycardia 01/2022
1	Bronchitis 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Exanthema (Rash) 01/2022
1	Sinusitis 01/2022
1	Joint Diseases (Joint Disease) 11/2019
1	Knee Injuries (Knee Injury) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Fatigue 01/2018
1	Lupus Nephritis 01/2017

Drug/Important Bio-Agent (IBA)

9	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 05/2013
8	Antirheumatic Agents (DMARD)IBA 01/2022 - 05/2007
7	Adalimumab (Humira)FDA Link 02/2022 - 02/2007
7	Janus Kinase InhibitorsIBA 02/2022 - 04/2015
7	secukinumabIBA 12/2021 - 01/2016
6	tofacitinibIBA 02/2022 - 04/2015
6	Monoclonal AntibodiesIBA 11/2019 - 07/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2010
4	tanezumabIBA 01/2022 - 01/2013
4	Analgesics (Analgesic Drugs)IBA 01/2020 - 09/2014
4	Etanercept (Enbrel)FDA Link 12/2017 - 07/2004
4	Pharmaceutical PreparationsIBA 01/2016 - 11/2009
3	Prostaglandins AIBA 02/2022 - 01/2013
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 11/2004
3	fasinumabIBA 01/2021 - 07/2014
3	Nerve Growth Factor (NGF)IBA 11/2019 - 01/2013
3	Naproxen (Naprosyn)FDA LinkGeneric 01/2013 - 12/2005
3	rofecoxib (Vioxx)FDA Link 12/2005 - 05/2004
2	ametantrone (HAQ)IBA 02/2022 - 04/2011
2	apremilastIBA 01/2022 - 07/2018
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2019
2	Biosimilar PharmaceuticalsIBA 04/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 03/2020 - 10/2012
2	ChemokinesIBA 03/2020 - 12/2017
2	C-Reactive ProteinIBA 02/2020 - 01/2016
2	sarilumabIBA 01/2020 - 06/2015
2	SolutionsIBA 12/2019 - 01/2014
2	TabletsIBA 12/2019 - 03/2012
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 12/2019 - 01/2019
2	peficitinibIBA 12/2019 - 01/2017
2	GlucocorticoidsIBA 12/2018 - 08/2008
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 12/2017
2	Certolizumab Pegol FDA Link 01/2017 - 04/2014
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 10/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 03/2012
2	Immunoglobulin G (IgG)IBA 10/2015 - 04/2010
2	AntigensIBA 04/2014 - 02/2007
2	VaccinesIBA 04/2014 - 02/2007
2	Abatacept (Orencia)FDA Link 05/2013 - 04/2011
2	rilonacept FDA Link 10/2012 - 08/2008
2	Interleukin-1 (Interleukin 1)IBA 07/2011 - 08/2008
2	Celecoxib (Celebrex)FDA Link 12/2007 - 11/2004
2	Nabumetone FDA LinkGeneric 11/2004 - 05/2004
1	bimekizumabIBA 07/2022
1	GLPG0634IBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	deucravacitinibIBA 01/2022
1	GP1111IBA 04/2020
1	Infliximab (Remicade)FDA Link 04/2020
1	spebrutinibIBA 03/2020
1	LigandsIBA 03/2020
1	CollagenIBA 03/2020
1	Janus KinasesIBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Delayed-Action PreparationsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	tocilizumab (atlizumab)FDA Link 01/2018
1	ABT-122IBA 12/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 10/2003
2	Analgesia 12/2019 - 12/2005
1	Precision Medicine 01/2022
1	Intra-Articular Injections 01/2019